More
An interview with Dr Elisabete Weiderpass, Director of the International Agency for Research on Cancer (IARC), has been published in the journal Nature Cancer. In the interview, Dr Weiderpass summarizes some of the achievements that IARC researchers accomplished in 2021. She describes IARC’s strategy to deliver cancer research that matters in 2022 and the years ahead, and explains how the COVID-19 pandemic has affected cancer control efforts internationally. She also highlights emerging topics that require particular attention from IARC and regulatory authorities.
The interview forms part of the journal’s “2021 in Review” focus, which comprises a series of specially commissioned articles in which leading experts in the cancer field offer their unique perspectives on the most exciting advances and the biggest challenges of 2021.
Cancer research that matters
Nat Cancer, Published online 21 December 2021;
https://doi.org/10.1038/s43018-021-00302-9
Scientists from the International Agency for Research on Cancer (IARC) and partner institutions h...
The monograph on aspartame, the first monograph in IARC Monographs Volume 134: Aspartame, Methyle...
The International Agency for Research on Cancer (IARC) is pleased to announce the launch of the C...